Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | CCR1 | P32246 | 2/20 | 0.61 |
| ▸ | CCR8 | P51685 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | MMP9 | P14780 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.61 |
| ▸ | MMP8 | P22894 | 1/20 | 0.61 |
| ▸ | THPO | P40225 | 1/20 | 0.61 |
| ▸ | MTOR | P42345 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | MMP13 | P45452 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29358836 | 1.00 | MMP2 (0.61) | MMP2TSHRCCR1CCR8KDM4E | |
| SCHEMBL10938107 | 0.98 | MMP2 (0.58) | MMP2TSHRCCR1CCR8KDM4E | |
| SCHEMBL4461988 | 0.98 | MMP2 (0.58) | MMP2TSHRCCR1CCR8KDM4E | |
| SCHEMBL5325898 | 0.83 | LMNA (0.58) | MMP2TSHRCCR1CCR8KDM4E | |
| SCHEMBL29241785 | 0.83 | LMNA (0.52) | MMP2TSHRCCR1CCR8KDM4E | |
| SCHEMBL31175945 | 0.83 | LMNA (0.58) | MMP2TSHRCCR1CCR8KDM4E | |
| SCHEMBL28129964 | 0.81 | TSHR (0.56) | MMP2TSHRCCR1CCR8KDM4E | |
| SCHEMBL22963304 | 0.80 | ALDH1A1 (0.66) | MMP2TSHRCCR1CCR8KDM4E | |
| Phenanthroline SCHEMBL29367277 | 0.76 | CCR1 (1.00) | MMP2TSHRCCR1CCR8KDM4E | |
| Phenanthroline SCHEMBL8312 | 0.76 | CCR1 (1.00) | MMP2TSHRCCR1CCR8KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 926 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119702019-A | Catalyst for catalyzing selective hydrogenation of quinoline and preparation method thereof | 湘潭大学 | 2025-03-28 | — | — | CN | claimed |
| CN-114164491-A | Ion-doped gadolinium-gallium garnet crystal and preparation method and application thereof | 山东大学 | 2022-03-11 | — | — | CN | claimed |
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | claimed |
| CN-105753838-A | Novel high-regioselectivity amination method of quinoline derivatives | 安阳师范学院 | 2016-07-13 | — | — | CN | claimed |
| CN-103604791-A | Fluorescence spectroscopic method for measuring azides ions | UNIV GUANGXI NORMAL | 2014-02-26 | — | — | CN | claimed |
| US-7981578-B2 | Additive containing photoconductors | XEROX CORPORATION (US) | 2011-07-19 | — | — | US | claimed |
| US-20090246660-A1 | ADDITIVE CONTAINING PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-10-01 | — | — | US | claimed |
| CN-1914173-A | Quinolines useful in treating cardiovascular disease | WYETH CORP (US) | 2007-02-14 | — | — | CN | claimed |
| CN-1067380-C | Method for conversion of substituted 8-chloroquinolines to substituted 8-hydroxyquinolines | AMERICAN CYANAMID CO (US) | 2001-06-20 | — | — | CN | claimed |
| EP-0744399-B1 | Conversion of substituted 8-chloroquinolines to substituted 8-hydroxyquinolines | AMERICAN CYANAMID CO (US) | 2000-10-25 | — | — | EP | claimed |
| EP-0505890-B1 | Process for producing a styrenic polymer | IDEMITSU KOSAN CO (JP) | 1997-05-28 | — | — | EP | claimed |
| CN-1146989-A | Method for conversion of substituted 8-chloroquinolines to substituted 8-hydroxyquinolines | AMERICAN CYANAMID CO (US) | 1997-04-09 | — | — | CN | claimed |
| US-5597924-A | Coversion of substituted 8-chloroquinolines to substituted 8-hydroxyquinolines | AMERICAN CYANAMID COMPANY (US) | 1997-01-28 | — | — | US | claimed |
| EP-0744399-A2 | Conversion of substituted 8-chloroquinolines to substituted 8-hydroxyquinolines | American Cyanamid Company (US) | 1996-11-27 | — | — | EP | claimed |
| EP-0271260-B1 | Supersensitization of silver halide emulsions | MINNESOTA MINING & MFG (US) | 1995-01-04 | — | — | EP | claimed |
| US-4873184-A | ADDITION OF A METAL COMPLEXING AGENT TO THE EMULSION; HIGH SPEED | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-10-10 | — | — | US | claimed |
| EP-0271260-A2 | Supersensitization of silver halide emulsions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-06-15 | — | — | EP | claimed |
| US-4496727-A | ORGANIC PIGMENTS; PLASTICS; LACQUERS; INKS; COATINGS; COLOR FASTNESS | CIBA-GEIGY CORPORATION (US) | 1985-01-29 | — | — | US | claimed |
| US-3970461-A | Fogged, direct-positive silver halide emulsion containing carbocyanine dye having indolenine nucleus | FUJI PHOTO FILM CO., LTD. (JA) | 1976-07-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | MMP2 4517/4885TSHR 3267/4885CCR1 957/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.